SOPH
SOPHiA GENETICS delivers data-driven medicine for precision oncology and rare disorders by providing an AI- and cloud-powered platform that analyzes diverse health data to generate real-time, actionable insights. The company operates globally, enabling clinicians, providers, and biopharma partners to accelerate diagnosis, treatment decisions, and research through multi-omics data analytics, including genomics, radiomics, and multimodal data. It emphasizes data governance and privacy while helping healthcare institutions translate complex datasets into actionable patient care across oncology and hereditary diseases.
No recent deals for this company.